previous next How Tweet It Is

djx rt f r&c pe&vc wsj b AllThingsDigital AllThingsDigital The Shops The Shops More BigCharts Financial News Professor Journal SmartMoney Student Journal Virtual Stock Exchange WSJ Classifieds WSJ Classroom WSJ Radio WSJ Wine WSJ Live Updated Privacy Policy »
Home Magazine sore throat This Week's Edition Past Editions Daily All Coverage Barron's Take Weekday Trader Up & Down Wall St. Daily Getting Technical Striking Price Daily Wall Street's Best Minds Read This, Spike That Stocks to Watch Today Income Investing Tech Trader Daily Focus on Funds Emerging Markets Inside Scoop Q&A Investing Ideas Overview Barron's Picks & Pans Mutual Funds / ETFs Stocks sore throat Center Commodities Center Bonds Center Options Center Barron's Take Weekday Trader Stock Alert Inside Scoop Ahead of the Crowd Focus on Funds Stocks to Watch Today Barron's Roundtable Top Advisors Overview Top 100 Advisors Top 100 Women Advisors Top 100 Independent Advisors Top 1,000 Advisors Advisor Profiles Market Data Market Data Center Market Lab Economic Calendar New Portfolio Old Portfolio Stock Grader Stock & Fund Tables Barron's 400 PENTA Penta Magazine Penta Daily Penta Archives Paid Advisor Directory
Dow sore throat Jones Reprints: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com See a sample sore throat reprint in PDF format Order a reprint of this article now
W. W. Grainger (GWW: NYSE) By Raymond James & Associates ($258.61, Oct. 15, 2013) We are maintaining our Outperform sore throat rating, cutting our price target to $268 from $280 and trimming our estimates for W.W. Grainger slightly ahead of its third-quarter ...
Sell Time Warner Cable, Buy Comcast
previous next How Tweet It Is
For more than a decade, investing in Latin America was all about Brazil. But it's power is waning, and the bigger opportunities -- and growth drivers -- are in Mexico. Investors should take note. Bonds Go Back to Being Boring
With the Federal Reserve forced to wait until spring before attempting to scale back its bond-buying program, and no more self-inflicted government shutdowns scheduled until early next year, bonds should be less volatile. Now it's time to look for returns in bonds that carry a bit more credit risk. Why Options Funds Aren't a Buy
Subscriber Content Read Preview 3. The New Latin America
Subscriber Content Read Preview 5. Bonds Go Back to Being Boring 1. The 10% Solution 34 comments 2. Obama's Woeful Jobs Record 26 comments 3. Perilous Course sore throat 15 comments 4. Deflating the Inflation Myth 11 comments 5. Why Options Funds Aren't a Buy 7 comments See Full List
“ I'm sure Stockman knows that his plan won't come to pass. But at least he is setting the stage for higher taxes on the high end. That is inevitable. ” — JAMES BURNHAM On David Stockman: Soak the Rich
Get Emails from Barron's
• Must enter an email address.
• Invalid entry: Please type the verification code again. sore throat